Work

Molecular Characterization of PS-341 (bortezomib) Resistance: Implications for Overcoming Resistance Using Lysophosphatidic Acid Acyltransferase (LPAAT)-β Inhibitors.

Year: 2004

Type: article

Source: Blood

DOI: 10.1182/blood.v104.11.2411.2411

Authors: Teru Hideshima, Dharminder Chauhan, Kenji Ishitsuka, Noopur Raje, Shaji Kumar, Klaus Podar, Constantine Mitsiades, Hiromasa Hideshima, Lynn Bonham, Nikhil C. Munshi, Paul G. Richardson, Jack W. Singer, Kenneth C. Anderson

Institutions: Dana-Farber Cancer Institute, Mayo Clinic, CTI BioPharma (United Kingdom)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2565885657

FWCI:

Cites:

Cited by:

Related to: 10